Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.59 |
| ▸ | NPY1R | P25929 | 9/20 | 0.59 |
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.43 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7440625 | 0.94 | NPY4R (0.53) | NPY4RNPY5RNPY1RNPY2REPHX2 | |
| SCHEMBL7443489 | 0.93 | NPY4R (0.48) | NPY4RNPY5RNPY1RNPY2REPHX2 | |
| SCHEMBL7439753 | 0.93 | NPY4R (0.48) | NPY4RNPY5RNPY1RNPY2REPHX2 | |
| SCHEMBL7434794 | 0.92 | NPY4R (0.51) | NPY4RNPY5RNPY1RNPY2REPHX2 | |
| SCHEMBL7441257 | 0.91 | NPY4R (0.54) | NPY4RNPY5RNPY1RNPY2REPHX2 | |
| SCHEMBL7443504 | 0.90 | EPHX2 (0.48) | NPY4RNPY5RNPY1RNPY2REPHX2 | |
| SCHEMBL30496961 | 0.90 | NPY4R (0.61) | NPY4RNPY5RNPY1RNPY2RNOD1 | |
| SCHEMBL29738690 | 0.90 | NPY4R (0.61) | NPY4RNPY5RNPY1RNPY2RNOD1 | |
| SCHEMBL29640340 | 0.90 | NPY4R (0.61) | NPY4RNPY5RNPY1RNPY2RNOD1 | |
| SCHEMBL30496979 | 0.90 | NPY4R (0.61) | NPY4RNPY5RNPY1RNPY2RNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0577775-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1995-01-11 | — | — | EP | claimed |
| US-5332726-A | Anticoagulant | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-07-26 | — | — | US | claimed |
| EP-0577775-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-01-12 | — | — | EP | claimed |
| WO-1992017196-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-10-15 | — | — | WO | claimed |
| EP-0577775-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5332726-A | Anticoagulant | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0577775-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-01-12 | — | — | EP | disclosed |
| WO-1992017196-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-10-15 | — | — | WO | disclosed |